Menu

Star on GitHub · 3.2k

CVE-2022-22111

8.8 · HIGH

In DayByDay CRM, version 2.2.0 is vulnerable to missing authorization.

Published Jan 5, 2022CWE-862EPSS 1.00%

Overview

CVE-2022-22111 is a high-severity vulnerability. It was published on January 5, 2022 and has a CVSS 3.1 base score of 8.8 (HIGH).

This vulnerability has a CVSS 3.1 base score of 8.8, rated HIGH. It can be exploited remotely over the network. Some level of privileges is required for exploitation.

Technical description

In DayByDay CRM, version 2.2.0 is vulnerable to missing authorization. Any application user in the application who has update user permission enabled is able to change the password of other users, including the administrator’s. This allows the attacker to gain access to the highest privileged user in the application.

Remediation

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Frequently asked questions

What is CVE-2022-22111?

CVE-2022-22111 is a high-severity vulnerability. It was published on January 5, 2022 and has a CVSS 3.1 base score of 8.8 (HIGH).

How severe is CVE-2022-22111?

This vulnerability has a CVSS 3.1 base score of 8.8, rated HIGH. It can be exploited remotely over the network. Some level of privileges is required for exploitation.

How do I fix or remediate CVE-2022-22111?

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2022-22111?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2022-22111 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.

Related HIGH CVEs from 2022

View all